Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Jesse A. May"'
Autor:
Jesse A. May, Najam A. Sharif
Publikováno v:
Expert Review of Ophthalmology. 6:105-120
Although several classes of drugs, including FP-receptor prostaglandin agonist analogs, are available to treat elevated intraocular pressure (IOP) associated with glaucoma, novel pharmaceuticals to treat this potentially blinding disease are still be
Autor:
Jesse A. May, Najam A. Sharif, Hwang-Hsing Chen, John C. Liao, Curtis R. Kelly, Richard A. Glennon, Richard Young, Jun-Xu Li, Kenner C. Rice, Charles P. France
Publikováno v:
Pharmacology Biochemistry and Behavior. 91:307-314
AL-38022A is a novel synthetic serotonergic (5-HT) ligand that exhibited high affinity for each of the 5-HT2 receptor subtypes (Ki ≤ 2.2 nM), but a significantly lower (>100-fold less) affinity for other 5-HT receptors. In addition, AL-38022A displ
Autor:
Mark R. Hellberg, Bryon S. Severns, William F. Holt, Richard Young, Richard A. Glennon, Thomas R. Dean, Najam A. Sharif, Hwang-Hsing Chen, Curtis R. Kelly, Marsha A. McLaughlin, Jesse A. May
Publikováno v:
Journal of medicinal chemistry. 58(22)
Recently, it has been reported that 5-HT2 receptor agonists effectively reduce intraocular pressure (IOP) in a nonhuman primate model of glaucoma. Although 1-[(2S)-2-aminopropyl]indazol-6-ol (AL-34662) was shown to have good efficacy in this nonhuman
Autor:
Zixia Feng, Tom Brittain, Mark R. Hellberg, Grant Carr, Jesse A. May, Macarena Irigoyen, Damon Colbert, Shouxi Xu, Alfred N. Van Hoek, Peter M. Brown, Rajkumar V. Patil, Alok K. Mitra, Kulandaiappan Varadaraj, M. B. Wax, Andrew Rusinko, Najam A. Sharif, S. Sindhu Kumari
Publikováno v:
Chemical biologydrug design. 87(5)
Aquaporins (AQPs) are a family of membrane proteins that function as channels facilitating water transport in response to osmotic gradients. These play critical roles in several normal physiological and pathological states and are targets for drug di
Publikováno v:
Journal of Medicinal Chemistry. 49:318-328
Serotonin 5-HT(2) receptor agonists have been identified as a potential new class of agents for the treatment of ocular hypertension and glaucoma. The initially reported tryptamine analogues displayed either poor solution stability, potent central ne
Autor:
Marsha A. McLaughlin, Andrew Rusinko, Vincent M. Lynch, Hwang-Hsing Chen, Jesse A. May, Najam A. Sharif
Publikováno v:
Journal of Medicinal Chemistry. 46:4188-4195
Serotonin 5-HT2 receptor agonists have recently been shown to be effective in lowering intraocular pressure in nonhuman primates and represent a potential new class of antiglaucoma agents. As part of an effort to identify new selective agonists at th
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 306:301-309
Published investigations of serotonin-1A (5-hydroxytryptamine1A; 5-HT1A) receptor agonists and serotonin-2A (5-hydroxytryptamine2A; 5-HT2A) receptor antagonists in nonprimate species provide conflicting results with regard to their intraocular pressu
Autor:
Jesse A. May, Ernest U. Do, Robert Selliah, Judith Egan, Anura P. Dantanarayana, Karen S. Haggard
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 44:173-183
A method for the preparation of tritium labeled travoprost, a new ocular hypotensive prostaglandin, is described. A highly selective catalytic deiodination has been identified which provides [phenyl-2-3H]-travoprost in a single synthetic step from 2
Autor:
Sharon Gross, William S. Sly, Hwang-Hsing Chen, Marsha A. McLaughlin, Jesse A. May, Thomas R. Dean, John B. Liao
Publikováno v:
Bioorganic & Medicinal Chemistry. 8:957-975
Novel non-chiral 2H-thieno[3,2-e]- and [2,3-e]-1,2-thiazine-6-sulfonamide 1,1-dioxides were synthesized for evaluation as potential candidates for the treatment of glaucoma. All of the compounds prepared were potent high affinity inhibitors of human
Publikováno v:
Journal of Heterocyclic Chemistry. 36:65-73
3-(Methoxymethoxymethyl)-2-thiophenesulfonamides and 3-hydroxymethyl-N-methoxymethyl-2-thiophenesulfonamides have been shown to undergo cyclization when treated under anhydrous acidic conditions to provide the novel 2,3-dihydro-5H-thieno[2,3-e]-4,1,2